查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
抗感染药市场：2023-2028 年全球行业趋势、份额、规模、增长、机遇和预测
市场调查报告书
商品编码
1207152

抗感染药市场：2023-2028 年全球行业趋势、份额、规模、增长、机遇和预测

Anti-infectives Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

2022年全球抗感染市场规模将达到1302亿美元。 展望未来，IMARC Group 预测到 2028 年将达到 1576 亿美元，显示 2023 年至 2028 年之间的增长率 (CAGR) 为 3.46%。

抗感染药是对抗感染、抑制感染传播或彻底杀死感染病原体的药物。 这些药物包括抗生素、抗病毒药、抗真菌药、抗疟药、驱虫药、抗原虫药等。 它通常通过口服、肠胃外和局部等途径给药。 广泛用于治疗肺炎、肺结核等轻微感染。 它还用于严重感染风险高的常规程序和手术，例如剖腹产和关节置换术。

抗感染药市场趋势

  • 全球抗感染药市场的主要驱动因素是全球传染病数量的增加。 抗感染药物用于治疗病毒、细菌、寄生虫和真菌等感染。 此外，天然产物、群体感应抑製剂、生物膜破坏剂、镓基药物、环糊精抑製剂和光基抗菌剂等不同策略的新药开发正在推动市场增长。我正在获得动力. 与此同时，药物发现程序的最新创新，如干细胞和片上器官 (OOC) 技术，正在加强药物发现测试过程，并为市场创造光明的前景。 此外，由于 COVID-19 疾病的出现和曲霉菌病、侵袭性念珠菌病和粘菌病等诱发的感染，产品采用率的提高正在加强市场增长。 此外，越来越多的新型抗感染药获得监管部门批准也是推动增长的一个因素。 此外，政府实施利好政策、加大对创新药物开发的投入、公众对传染病的认识提高、医疗基础设施的快速改善等都有望在未来几年推动市场增长。我是这里。

主要市场细分

  • IMARC Group 分析了全球抗感染药市场报告每个子细分市场的主要趋势，并提供了 2023 年至 2028 年全球、区域和国家层面的预测。 该报告根据类型、给药途径和分销渠道对市场进行分类。

按类型细分

  • 抗菌剂
  • 抗真菌剂
  • 抗病毒剂

按给药途径分类

  • 外用
  • 口语
  • 静脉给药 (IV)
  • 其他

按销售渠道细分

  • 医院药房
  • 零售药房
  • 专业药房
  • 在线商店
  • 其他

按地区划分

  • 北美
  • 美国
  • 加拿大
  • 亚太地区
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳大利亚
  • 印度尼西亚
  • 其他
  • 欧洲
  • 德国
  • 法国
  • 英国
  • 意大利
  • 西班牙
  • 俄罗斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中东和非洲

本报告中回答的关键问题

  • 全球抗感染药市场到目前为止表现如何，未来几年会是什么样子？
  • COVID-19 对全球抗感染药市场有何影响？
  • 主要的区域市场是什么？
  • 市场是如何按类型细分的？
  • 基于给药途径的市场细分是什么？
  • 按分销渠道划分的市场细分情况如何？
  • 行业价值链中有哪些不同阶段？
  • 该行业的主要驱动因素和挑战是什么？
  • 全球抗感染药市场的结构和主要参与者是什么？
  • 该行业的竞争程度如何？

内容

第一章前言

第 2 章研究方法和范围

  • 调查的目的
  • 利益相关者
  • 数据源
    • 主要信息
    • 次要信息
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章执行摘要

第四章介绍

  • 概览
  • 主要行业趋势

第五章全球抗感染药物市场

  • 市场概览
  • 市场结果
  • COVID-19 的影响
  • 市场预测

第 6 章按类型划分的市场细分

  • 抗菌剂
    • 市场趋势
    • 市场预测
  • 抗真菌剂
    • 市场趋势
    • 市场预测
  • 抗病毒剂
    • 市场趋势
    • 市场预测

第 7 章按管理划分的市场细分

  • 外科学
    • 市场趋势
    • 市场预测
  • 口服剂
    • 市场趋势
    • 市场预测
  • 静脉给药 (IV)
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第 8 章分销渠道市场细分

  • 医院药房
    • 市场趋势
    • 市场预测
  • 零售药房
    • 市场趋势
    • 市场预测
  • 专业药房
    • 市场趋势
    • 市场预测
  • 在线商店
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第 9 章按区域划分的市场细分

  • 北美
    • 美国
      • 市场趋势
      • 市场预测
    • 加拿大
      • 市场趋势
      • 市场展望
  • 亚太地区
    • 中国
      • 市场趋势
      • 市场展望
    • 日本
      • 市场趋势
      • 市场预测
    • 印度
      • 市场趋势
      • 市场展望
    • 韩国市场
      • 市场趋势
      • 市场展望
    • 澳大利亚
      • 市场趋势
      • 市场展望
    • 印度尼西亚
      • 市场趋势
      • 市场展望
    • 其他
      • 市场趋势
      • 市场预测
  • 欧洲
    • 德国
      • 市场趋势
      • 市场展望
    • 法国
      • 市场趋势
      • 市场预测
    • 英国
      • 市场趋势
      • 市场预测
    • 意大利
      • 市场趋势
      • 市场展望
    • 西班牙
      • 市场趋势
      • 市场展望
    • 俄罗斯
      • 市场趋势
      • 市场展望
    • 其他
      • 市场趋势
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场趋势
      • 市场展望
    • 墨西哥
      • 市场趋势
      • 市场展望
    • 其他
      • 市场趋势
      • 市场预测
  • 中东和非洲
    • 市场趋势
    • 按国家/地区划分的市场细分
    • 市场展望

第 10 章 SWOT 分析

  • 概览
  • 强度
  • 弱点
  • 机会
  • 威胁

第11章价值链分析

第12章搬运工五力分析

  • 概览
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章竞争格局

  • 市场结构
  • 主要公司
  • 主要公司简介
    • Abbott Laboratories
    • Cipla Health Ltd.（Cipla Limited）
    • F. Hoffmann-La Roche AG
    • GlaxoSmithKline plc
    • Glenmark Pharmaceuticals Limited
    • Johnson & Johnson
    • Lupin Limited
    • Sandoz AG（Novartis AG）
    • Sun Pharmaceutical Industries Limited
Product Code: SR1323A624_Report

The global anti-infectives market size reached US$ 130.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 157.6 Billion by 2028, exhibiting a growth rate (CAGR) of 3.46% during 2023-2028.

Anti-infectives are medicines that act against infections, either by inhibiting the spread or killing the infectious agent outright. These medicines include antibiotics, antivirals, antifungals, antimalarials, anthelmintics, and antiprotozoals. They are generally administered through oral, parenteral, and topical routes. They are widely used to treat minor infectious diseases, including pneumonia and tuberculosis. Apart from this, anti-infectives are also utilized during routine procedures and surgeries, such as cesarian section and joint replacement, which are associated with a high risk of severe infection.

Anti-infectives Market Trends:

  • The global anti-infectives market is primarily driven by rising incidences of infectious diseases across the globe. Anti-Infinitives are used to treat infections, including viruses, bacteria, parasites, and fungi. Additionally, the development of novel drugs that are formulated using different strategies, such as natural products, quorum sensing inhibitors, biofilm disruptors, gallium-based drugs, cyclodextrin inhibitors, and light-based antimicrobials, are providing an impetus to the market growth. In line with this, the latest innovations in drug discovery procedures, such as stem cells and organ-on-chip (OOC) technologies, to enhance drug trial processes are creating a positive outlook for the market. Furthermore, the increasing product adoption due to the advent of the COVID-19 disease and induced infections, such as aspergillosis, invasive candidiasis, and mucormycosis, is strengthening the growth of the market. Besides this, the increasing number of new anti-infective drugs being approved by the regulatory authorities is acting as another growth-inducing factor. Moreover, the implementation of favorable government policies, rising investments in developing new and innovative drugs, increasing awareness among individuals about infectious diseases, and rapidly improving healthcare infrastructure are anticipated to impel the growth of the market in the coming years.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global anti-infectives market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, route of administration and distribution channel.

Breakup by Type:

  • Antibacterial
  • Antifungal
  • Antiviral

Breakup by Route of Administration:

  • Topical
  • Oral
  • Intravenous (IV)
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Speciality Pharmacies
  • Online Stores
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Cipla Health Ltd. (Cipla Limited), F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Johnson & Johnson, Lupin Limited, Sandoz AG (Novartis AG) and Sun Pharmaceutical Industries Limited.

Key Questions Answered in This Report:

  • How has the global anti-infectives market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global anti-infectives market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global anti-infectives market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Anti-infectives Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Antibacterial
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Antifungal
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Antiviral
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Topical
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Intravenous (IV)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Speciality Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Online Stores
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Cipla Health Ltd. (Cipla Limited)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 F. Hoffmann-La Roche AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 GlaxoSmithKline plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Glenmark Pharmaceuticals Limited
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Johnson & Johnson
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Lupin Limited
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Sandoz AG (Novartis AG)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Sun Pharmaceutical Industries Limited
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Anti-infectives Market: Major Drivers and Challenges
  • Figure 2: Global: Anti-infectives Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Anti-infectives Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Anti-infectives Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Anti-infectives Market: Breakup by Route of Administration (in %), 2022
  • Figure 6: Global: Anti-infectives Market: Breakup by Distribution Channel (in %), 2022
  • Figure 7: Global: Anti-infectives Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Anti-infectives (Antibacterial) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Anti-infectives (Antibacterial) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Anti-infectives (Antifungal) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Anti-infectives (Antifungal) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Anti-infectives (Antiviral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Anti-infectives (Antiviral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Anti-infectives (Topical) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Anti-infectives (Topical) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Anti-infectives (Oral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Anti-infectives (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Anti-infectives (Intravenous (IV)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Anti-infectives (Intravenous (IV)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Anti-infectives (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Anti-infectives (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Anti-infectives (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Anti-infectives (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Anti-infectives (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Anti-infectives (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Anti-infectives (Speciality Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Anti-infectives (Speciality Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Anti-infectives (Online Stores) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Anti-infectives (Online Stores) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Anti-infectives (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Anti-infectives (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: North America: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: North America: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: United States: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: United States: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Canada: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Canada: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Asia-Pacific: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Asia-Pacific: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: China: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: China: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Japan: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Japan: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: India: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: India: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: South Korea: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: South Korea: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Australia: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Australia: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Indonesia: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Indonesia: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Others: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Others: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Europe: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Europe: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Germany: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Germany: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: France: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: France: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: United Kingdom: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: United Kingdom: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Italy: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Italy: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Spain: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Spain: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Russia: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Russia: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Others: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Others: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Latin America: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Latin America: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Brazil: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Brazil: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Mexico: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Mexico: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Others: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Others: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Middle East and Africa: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Middle East and Africa: Anti-infectives Market: Breakup by Country (in %), 2022
  • Figure 80: Middle East and Africa: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Global: Anti-infectives Industry: SWOT Analysis
  • Figure 82: Global: Anti-infectives Industry: Value Chain Analysis
  • Figure 83: Global: Anti-infectives Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Anti-infectives Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Anti-infectives Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Anti-infectives Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
  • Table 4: Global: Anti-infectives Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 5: Global: Anti-infectives Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Anti-infectives Market: Competitive Structure
  • Table 7: Global: Anti-infectives Market: Key Players